PMC:7361216 / 8034-8638
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T93 | 63-70 | Body_part | denotes | mannose | http://purl.org/sig/ont/fma/fma82801 |
T94 | 111-130 | Body_part | denotes | cerebrospinal fluid | http://purl.org/sig/ont/fma/fma20935 |
T95 | 364-371 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T28 | 111-130 | Body_part | denotes | cerebrospinal fluid | http://purl.obolibrary.org/obo/UBERON_0001359 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T19 | 151-169 | Disease | denotes | multiple sclerosis | http://purl.obolibrary.org/obo/MONDO_0005301 |
T20 | 289-309 | Disease | denotes | inflammatory disease | http://purl.obolibrary.org/obo/MONDO_0021166 |
T21 | 595-603 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T100 | 3-4 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T101 | 182-188 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
T102 | 362-363 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T103 | 431-437 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
T104 | 523-525 | http://purl.obolibrary.org/obo/CLO_0007874 | denotes | MS |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T67 | 63-70 | Chemical | denotes | mannose | http://purl.obolibrary.org/obo/CHEBI_37684 |
T68 | 82-89 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T69 | 257-264 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
T70 | 343-350 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T71 | 364-371 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T72 | 372-379 | Chemical | denotes | carrier | http://purl.obolibrary.org/obo/CHEBI_78059 |
T73 | 512-519 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T74 | 523-525 | Chemical | denotes | MS | http://purl.obolibrary.org/obo/CHEBI_73613 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T30 | 33-40 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
T31 | 302-309 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T59 | 63-70 | Chemical | denotes | mannose | http://purl.obolibrary.org/obo/CHEBI_37684 |
T60 | 82-89 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T61 | 343-350 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T62 | 364-371 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T63 | 512-519 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T22 | 595-603 | Species | denotes | COVID‐19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T52 | 0-219 | Sentence | denotes | In a different neuroinflammatory disease antibodies to cryptic mannose containing glycans were observed in the cerebrospinal fluid of individuals with multiple sclerosis, and in its animal model EAE (Wang et al., 2014). |
T53 | 220-310 | Sentence | denotes | There again is some precedent for an antigen‐specific therapy for an inflammatory disease. |
T54 | 311-462 | Sentence | denotes | Injection of these oligomannose glycans coupled to a protein carrier reduced the clinical severity of paralysis in this animal model (Wang, Bhat et al. |
T55 | 463-469 | Sentence | denotes | 2014). |
T56 | 470-604 | Sentence | denotes | The success in parlaying the oligomannose glycans in MS and in its EAE model, could be emulated in strategies for therapy of COVID‐19. |
LitCovid-sample-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T22 | 111-130 | Body_part | denotes | cerebrospinal fluid | http://purl.obolibrary.org/obo/UBERON_0001359 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
246 | 15-40 | Disease | denotes | neuroinflammatory disease | MESH:D003141 |
241 | 55-62 | Gene | denotes | cryptic | Gene:55997 |
242 | 63-70 | Chemical | denotes | mannose | MESH:D008358 |
243 | 82-89 | Chemical | denotes | glycans | MESH:D011134 |
247 | 151-169 | Disease | denotes | multiple sclerosis | MESH:D009103 |
244 | 330-350 | Chemical | denotes | oligomannose glycans | |
248 | 413-422 | Disease | denotes | paralysis | MESH:D010243 |
245 | 499-519 | Chemical | denotes | oligomannose glycans | |
249 | 595-603 | Disease | denotes | COVID‐19 | MESH:C000657245 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T89 | 362-371 | Protein | denotes | a protein | https://www.uniprot.org/uniprot/Q38365|https://www.uniprot.org/uniprot/P25244|https://www.uniprot.org/uniprot/P25243|https://www.uniprot.org/uniprot/P15966|https://www.uniprot.org/uniprot/P09676|https://www.uniprot.org/uniprot/P07394|https://www.uniprot.org/uniprot/P03632|https://www.uniprot.org/uniprot/P03610|https://www.uniprot.org/uniprot/O64306 |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T93 | 63-70 | Body_part | denotes | mannose | http://purl.org/sig/ont/fma/fma82801 |
T94 | 111-130 | Body_part | denotes | cerebrospinal fluid | http://purl.org/sig/ont/fma/fma20935 |
T95 | 364-371 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-sample-PD-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 111-130 | http://purl.obolibrary.org/obo/MAT_0000499 | denotes | cerebrospinal fluid |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T22 | 151-169 | Disease | denotes | multiple sclerosis | http://purl.obolibrary.org/obo/MONDO_0005301 |
T23 | 289-309 | Disease | denotes | inflammatory disease | http://purl.obolibrary.org/obo/MONDO_0021166 |
T24 | 595-603 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T14 | 413-422 | Phenotype | denotes | paralysis | http://purl.obolibrary.org/obo/HP_0003470 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T14 | 413-422 | Phenotype | denotes | paralysis | http://purl.obolibrary.org/obo/HP_0003470 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T52 | 0-219 | Sentence | denotes | In a different neuroinflammatory disease antibodies to cryptic mannose containing glycans were observed in the cerebrospinal fluid of individuals with multiple sclerosis, and in its animal model EAE (Wang et al., 2014). |
T53 | 220-310 | Sentence | denotes | There again is some precedent for an antigen‐specific therapy for an inflammatory disease. |
T54 | 311-462 | Sentence | denotes | Injection of these oligomannose glycans coupled to a protein carrier reduced the clinical severity of paralysis in this animal model (Wang, Bhat et al. |
T55 | 463-469 | Sentence | denotes | 2014). |
T56 | 470-604 | Sentence | denotes | The success in parlaying the oligomannose glycans in MS and in its EAE model, could be emulated in strategies for therapy of COVID‐19. |
LitCovid-sample-Glycan
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 63-70 | http://rdf.glyconavi.org/CarTNa/CarTNa218/trivialname | denotes | mannose |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
241 | 55-62 | Gene | denotes | cryptic | Gene:55997 |
242 | 63-70 | Chemical | denotes | mannose | MESH:D008358 |
243 | 82-89 | Chemical | denotes | glycans | MESH:D011134 |
244 | 330-350 | Chemical | denotes | oligomannose glycans | |
245 | 499-519 | Chemical | denotes | oligomannose glycans | |
246 | 15-40 | Disease | denotes | neuroinflammatory disease | MESH:D003141 |
247 | 151-169 | Disease | denotes | multiple sclerosis | MESH:D009103 |
248 | 413-422 | Disease | denotes | paralysis | MESH:D010243 |
249 | 595-603 | Disease | denotes | COVID‐19 | MESH:C000657245 |